Scarica l'app Stockscreener
7.23
1.12%
0.08
Dopo l'orario di chiusura:
7.23
Precedente Chiudi:
$7.15
Aprire:
$7.15
Volume 24 ore:
1.95M
Relative Volume:
0.95
Capitalizzazione di mercato:
$880.45M
Reddito:
-
Utile/perdita netta:
$-29.07M
Rapporto P/E:
-24.93
EPS:
-0.29
Flusso di cassa netto:
$-31.85M
1 W Prestazione:
+0.28%
1M Prestazione:
-3.47%
6M Prestazione:
+62.84%
1 anno Prestazione:
+145.08%
Intervallo 1D:
$6.97
$7.305
Intervallo di 1 settimana:
$6.97
$7.52
Portata 52W:
$2.36
$8.78
Trevi Therapeutics Inc Stock (TRVI) Company Profile
Nome
Trevi Therapeutics Inc
Settore
Industria
Telefono
203-304-2499
Indirizzo
195 CHURCH STREET, NEW HAVEN, CT
Confronta TRVI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TRVI
Trevi Therapeutics Inc
|
7.23 | 885.32M | 0 | -29.07M | -31.85M | -0.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Trevi Therapeutics Inc Stock (TRVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-21 | Iniziato | Morgan Stanley | Overweight |
| 2025-07-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-05-28 | Iniziato | H.C. Wainwright | Buy |
| 2025-03-10 | Reiterato | Needham | Buy |
| 2025-03-10 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-12-12 | Reiterato | H.C. Wainwright | Buy |
| 2024-09-09 | Ripresa | Leerink Partners | Outperform |
| 2024-08-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-08-30 | Iniziato | Raymond James | Outperform |
| 2024-06-13 | Iniziato | Rodman & Renshaw | Buy |
| 2023-04-12 | Iniziato | B. Riley Securities | Buy |
| 2022-11-22 | Iniziato | SVB Leerink | Outperform |
| 2019-06-03 | Iniziato | BMO Capital Markets | Outperform |
| 2019-06-03 | Iniziato | Needham | Buy |
| 2019-06-03 | Iniziato | SVB Leerink | Outperform |
| 2019-06-03 | Iniziato | Stifel | Buy |
Mostra tutto
Trevi Therapeutics Inc Borsa (TRVI) Ultime notizie
Volume spikes in Trevi Therapeutics Inc. stock – what they meanTrade Volume Summary & Weekly Stock Breakout Alerts - Newser
Pattern recognition hints at Trevi Therapeutics Inc. upside2025 Top Decliners & Weekly Return Optimization Plans - Newser
Visualizing Trevi Therapeutics Inc. stock with heatmapsJuly 2025 Catalysts & Community Verified Swing Trade Signals - Newser
How to monitor Trevi Therapeutics Inc. with trend dashboards2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Tools to monitor Trevi Therapeutics Inc. recovery probabilityPortfolio Performance Summary & Stepwise Trade Execution Plans - Newser
Why Trevi Therapeutics Inc. is moving todayWeekly Trade Recap & AI Powered Market Entry Ideas - Newser
Trevi Therapeutics Inc.’s volatility index tracking explainedWeekly Investment Recap & Free Growth Oriented Trading Recommendations - Newser
Will Trevi Therapeutics Inc. stock go up soonJuly 2025 Closing Moves & Target Return Focused Stock Picks - Newser
Using AI based signals to follow Trevi Therapeutics Inc.Swing Trade & Technical Pattern Based Buy Signals - Newser
Is Trevi Therapeutics Inc. stock reversal real or fakeWeekly Market Outlook & Intraday High Probability Setup Alerts - Newser
Is Trevi Therapeutics Inc. stock ready for a breakoutJuly 2025 Action & Fast Exit and Entry Strategy Plans - Newser
Has Trevi Therapeutics Inc. found a price floorGDP Growth & Weekly High Return Forecasts - Newser
Sentiment analysis tools applied to Trevi Therapeutics Inc.July 2025 Technicals & Real-Time Stock Movement Alerts - Newser
Tools to assess Trevi Therapeutics Inc.’s risk profileTrade Exit Summary & AI Powered Buy/Sell Recommendations - Newser
Will Trevi Therapeutics Inc. benefit from rate cutsMarket Sentiment Summary & AI Powered Market Entry Ideas - khodrobank.com
What is the target price for Trevi Therapeutics Inc. stockQuarterly Portfolio Review & AI Forecasted Stock Moves - khodrobank.com
Volatility clustering patterns for Trevi Therapeutics Inc.Quarterly Profit Report & Community Verified Watchlist Alerts - Newser
Real time breakdown of Trevi Therapeutics Inc. stock performanceWeekly Trend Report & Entry and Exit Point Strategies - Newser
Is Trevi Therapeutics Inc. forming a bottoming baseWeekly Market Summary & Safe Capital Growth Tips - Newser
How does Trevi Therapeutics Inc. score in quality rankingsJuly 2025 Recap & Trade Opportunity Analysis Reports - khodrobank.com
Can Trevi Therapeutics Inc. keep up with sector leadersWeekly Gains Report & Stepwise Entry and Exit Trade Signals - khodrobank.com
Full technical analysis of Trevi Therapeutics Inc. stockJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - Newser
Applying chart zones and confluence areas to Trevi Therapeutics Inc.Weekly Volume Report & Technical Analysis for Trade Confirmation - Newser
Trevi Therapeutics Inc. stock trendline breakdown2025 Valuation Update & Growth-Oriented Investment Plans - Newser
Signal strength of Trevi Therapeutics Inc. stock in tech scannersEarnings Risk Summary & Weekly Return Optimization Plans - Newser
RSI Reset May Fuel Rebound in Trevi Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
What Fibonacci levels say about Trevi Therapeutics Inc. rebound2025 Growth vs Value & Reliable Breakout Forecasts - Newser
Will Trevi Therapeutics Inc. rebound enough to break evenWeekly Risk Summary & AI Powered Market Trend Analysis - Newser
How institutional ownership impacts Trevi Therapeutics Inc. stock2025 Top Gainers & Capital Efficient Trade Techniques - Newser
Trevi Therapeutics Inc. Stock Approaches Key Moving Average getLinesFromResByArray error: size == 0 - 더경남뉴스
Does Trevi Therapeutics Inc. have high return on assets2025 Biggest Moves & Fast Moving Stock Trade Plans - sundaytimes.kr
Trevi Therapeutics Inc Azioni (TRVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Trevi Therapeutics Inc Azioni (TRVI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SCIASCIA THOMAS | Chief Scientific Officer |
Mar 25 '25 |
Option Exercise |
1.43 |
2,631 |
3,762 |
224,004 |
| SCIASCIA THOMAS | Chief Scientific Officer |
Mar 25 '25 |
Sale |
6.60 |
2,631 |
17,365 |
221,373 |
| GOOD JENNIFER L | President & CEO |
Mar 21 '25 |
Option Exercise |
1.43 |
5,263 |
7,526 |
218,576 |
| GOOD JENNIFER L | President & CEO |
Mar 21 '25 |
Sale |
6.58 |
5,263 |
34,625 |
213,313 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):